phase readout
saveNCT06045806: A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
ACTIVE_NOT_RECRUITINGupdated 6d ago
community read0 votes
Sponsor: Celgene. Phase: PHASE3. Conditions: Multiple Myeloma
view source ↗
comments(0)
5-min edit window · permanent after that